HTFL vs ISRG vs IRTC vs RXRX vs NVCR

For growth investors, Heartflow, Inc.

Common Stock (HTFL) is the stronger pick with 39. 9% revenue growth year-over-year, versus 8. 3% for NovoCure Limited (NVCR). Intuitive Surgical, Inc. (ISRG) offers the better valuation at 54. 9x trailing P/E (41. 6x forward), making it the more compelling value choice. Analysts rate Heartflow, Inc. Common Stock (HTFL) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Intuitive Surgical, Inc.

is actually cheaper at 41. 6x.

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +59. 6%, compared to -89. 8% for NovoCure Limited (NVCR). Over 10 years, the gap is even starker: ISRG returned +513. 7% versus RXRX's -82. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), iRhythm Technologies, Inc.

(IRTC) is the lower-risk stock at 0. 73β versus Recursion Pharmaceuticals, Inc. 's 2. 99β — meaning RXRX is approximately 312% more volatile than IRTC relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 5% for iRhythm Technologies, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Heartflow, Inc.

Common Stock (HTFL) is pulling ahead at 39. 9% versus 8. 3% for NovoCure Limited (NVCR). On earnings-per-share growth, the picture is similar: iRhythm Technologies, Inc. grew EPS 61. 7% year-over-year, compared to 8. 1% for Heartflow, Inc. Common Stock. Over a 3-year CAGR, RXRX leads at 23. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -863. 4% for Recursion Pharmaceuticals, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -867. 9% for RXRX. At the gross margin level — before operating expenses — HTFL leads at 76. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Intuitive Surgical, Inc.

(ISRG) trades at 41. 6x forward P/E versus 26888. 6x for iRhythm Technologies, Inc. — 26847. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for RXRX: 249. 2% to $11. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, iRhythm Technologies, Inc.

(IRTC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 73), +354. 2% 10Y return). Recursion Pharmaceuticals, Inc. (RXRX) carries a higher beta of 2. 99 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IRTC: +354. 2%, RXRX: -82. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: HTFL is a mid-cap high-growth stock; ISRG is a mid-cap high-growth stock; IRTC is a small-cap high-growth stock; RXRX is a small-cap high-growth stock; NVCR is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.